Encompass Health Corporation (EHC)
NYSE: EHC · IEX Real-Time Price · USD
85.36
+0.09 (0.11%)
At close: Jul 19, 2024, 4:00 PM
85.29
-0.07 (-0.08%)
After-hours: Jul 20, 2024, 12:57 PM EDT
Encompass Health Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Encompass Health stock have an average target of 93.56, with a low estimate of 70 and a high estimate of 113. The average target predicts an increase of 9.61% from the current stock price of 85.36.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for EHC stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 10 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $95 → $100 | Strong Buy | Maintains | $95 → $100 | +17.15% | Jul 15, 2024 |
| Barclays | Barclays | Buy Maintains $108 → $113 | Buy | Maintains | $108 → $113 | +32.38% | Jul 10, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $100 | Buy | Initiates | $100 | +17.15% | Jul 10, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $94 | Buy | Reiterates | $94 | +10.12% | Jun 5, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $83 → $95 | Buy | Maintains | $83 → $95 | +11.29% | May 22, 2024 |
Financial Forecast
Revenue This Year
5.36B
from 4.80B
Increased by 11.70%
Revenue Next Year
5.85B
from 5.36B
Increased by 8.99%
EPS This Year
4.15
from 3.47
Increased by 19.52%
EPS Next Year
4.65
from 4.15
Increased by 12.11%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.6B | 6.2B | 6.7B |
| Avg | 5.4B | 5.8B | 6.4B |
| Low | 5.2B | 5.6B | 6.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 16.9% | 15.0% | 15.1% |
| Avg | 11.7% | 9.0% | 9.1% |
| Low | 8.0% | 4.5% | 4.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 4.53 | 5.23 | 5.80 |
| Avg | 4.15 | 4.65 | 5.19 |
| Low | 3.93 | 4.29 | 4.72 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 30.4% | 26.1% | 24.7% |
| Avg | 19.5% | 12.1% | 11.7% |
| Low | 13.3% | 3.5% | 1.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.